JPRN-UMIN000015873
Completed
未知
Comparison of SGLT2 inhibitors versus DPP-4 inhibitors for diabetic macular edema - Comparison of SGLT2 inhibitors versus DPP-4 inhibitors for diabetic macular edema
ConditionsType 2 diabetes mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus
- Sponsor
- Yokohama City University Medical Center
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients treated with photocoagulation, anti\-VEGF drugs or steroids to intraocular within 6 months 2\)severe ketosis, diabetic coma within 6 months 3\)severe infection, before operation, severe trauma 4\)severe hepatic dysfunction 5\)Patients who use of insulin, GLP\-1 receptor agonist or diuretic 6\)pregnacy 7\)Allergy for sitagliptin, nateglinide,liraglutide and exenatide 8\)Patients judged by the investigator to be ineligible for some other reason .
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The differecnces between SGLT2 and DPP4 inhibitors in blood glucose management and cardiac sympathetic nerve activityDiabetes mellitus (DM) patients complicated with heart failure (HF)JPRN-UMIN000032277Toho University40
Not yet recruiting
Not Applicable
SGLT2 inhibitor versus DPP-4 inhibitor on left ventricular ejection fraction measured by echocardiography in diabetic patients with acute myocardial infarction and midranged ejection fraction (EMPA-MI-MREF)Diseases of the circulatory systemKCT0007622Chonnam National University Hospital600
Completed
Not Applicable
Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end productsType 2 diabetesJPRN-UMIN000049408Akishima Clinic35
Terminated
Not Applicable
Combination of SGLT2 inhibitor and DPP-4 inhibitor as add-on therapy in subjects with type 2 diabetes inadequately controlled on insulin combined with metformin + DPP-4 inhibitor or metformin + SGLT2 inhibitor or metformin : open-label, multicenter trialKCT0004959Korea University Anam Hospital102
Completed
Not Applicable
Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?Diabete Type 2NCT05359341Sadat City University175